Walleye Capital
PBH icon

Walleye Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Walleye Capital’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,346
Closed -$249K – 5369
2023
Q3 		$249K Buy
+4,346
New +$263K ﹤0.01% 3387
2022
Q3 		– Sell
-28,156
Closed -$1.66M – 3453
2022
Q2 		$1.66M Buy
28,156
+20,230
+255% +$1.12M 0.05% 426
2022
Q1 		$420K Buy
+7,926
New +$458K 0.01% 1105

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Walleye Capital's PBH Position: Q4 2023 in Review

Walleye Capital sold out of Prestige Consumer Healthcare (PBH) in Q4 2023, closing a stake of 4,346 shares — an estimated $249K sold.

Walleye Capital first reported a position in PBH in Q1 2022 and held it in 3 quarters. The position peaked at $1.66M in Q2 2022. 288 funds tracked by Wall St. Rank hold PBH as of Q4 2023.

  • Walleye Capital reported no remaining Prestige Consumer Healthcare position as of Q4 2023 after selling out during the quarter.
  • Walleye Capital sold 4,346 Prestige Consumer Healthcare shares in Q4 2023, an estimated $249K.
  • Walleye Capital first reported a position in Prestige Consumer Healthcare in Q1 2022 and held it in 3 quarters.
  • Walleye Capital's Prestige Consumer Healthcare position peaked at $1.66M in Q2 2022.
  • 288 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.